Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISECONTROL)

This study has been terminated.
(At time of pre-specified 2nd interim analysis)
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
David Birnie, University of Ottawa Heart Institute
ClinicalTrials.gov Identifier:
NCT00800137
First received: November 26, 2008
Last updated: April 8, 2013
Last verified: April 2013